Gsa Capital Partners LLP Sutro Biopharma, Inc. Transaction History

Gsa Capital Partners LLP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	BUY	$2.92 - $5.33 $687,359 - $1.25 Million	235,397 New	235,397 $690,000
Q3 2023 Nov 15, 2023	BUY	$3.29 - $4.9 $222,910 - $331,994	67,754 New	67,754 $235,000
Q1 2023 May 12, 2023	SELL	$4.48 - $8.45 $105,029 - $198,101	-23,444 Reduced 53.24%	20,588 $95,000
Q4 2022 Feb 13, 2023	SELL	$5.41 - $8.08 $657,379 - $981,816	-121,512 Reduced 73.4%	44,032 $356,000
Q3 2022 Nov 14, 2022	SELL	$5.17 - $7.11 $271,792 - $373,779	-52,571 Reduced 24.1%	165,544 $919,000
Q2 2022 Aug 09, 2022	BUY	$3.41 - $8.95 $622,914 - $1.63 Million	182,673 Added 515.41%	218,115 $1.14 Million
Q1 2022 May 11, 2022	SELL	$7.78 - $15.31 $279,846 - $550,700	-35,970 Reduced 50.37%	35,442 $291,000
Q4 2021 Feb 14, 2022	BUY	$14.25 - $23.53 $1.02 Million - $1.68 Million	71,412 New	71,412 $1.06 Million

137

62.4M

77.1K

31.4K

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $105M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.